DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

BioMarin Pharmaceuticals (NASDAQ: BMRN)

85.83 1.40 (1.66%)

REAL-TIME: Last trade at

Extended Hours: $85.83 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

BMRN $85.83 1.66%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $85.48
Previous Close $84.43
Daily Range $84.26 - $86.34
52-Week Range $55.04 - $88.23
Market Cap $12.7B
P/E Ratio -95.94
Dividend (Yield) $0.00 (0.0%)
Volume 847,435
Average Daily Volume 1,136,734
Current FY EPS -$1.06





BioMarin Pharmaceuticals (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website:

News & Commentary Rss Feed

Is This Trend Making Gilead Sciences, Inc. Worry?

In a bid to control costs, healthcare payers are restricting who can be prescribed Gilead Sciences' Harvoni.

Amgen Claims It All

Gilead to Buy Knight Therapeutics' Priority Review Voucher - Analyst Blog

Will Catalyst Pharmaceuticals' (CPRX) Loss Narrow in Q3? - Analyst Blog

Stocks Hitting 52-Week Highs

Benzinga's Top Upgrades

Top Analyst Upgrades and Downgrades: BioMarin, BP, Genworth, Petrobras, Target and More

Why BioMarin Pharmaceutical Inc. Roared 14% Higher in October

BioMarin Pharmaceutical was among the best-performing biotech stocks in October. Find out why shares took off and whether or not BioMarin can head even higher.

Cramer Sees HP Entering Sector as Trouble for 3-D Printing Stocks

Can the Rally in BioMarin Pharmaceutical (BMRN) Shares Continue? - Tale of the Tape

See More BMRN News...

BMRN's Top Competitors

BMRN $85.83 (1.66%)
Current stock: BMRN
AMGN $162.81 (0.08%)
Current stock: AMGN
GILD $100.58 (-0.01%)
Current stock: GILD
BIIB $303.55 (1.49%)
Current stock: BIIB